Latest news
Porton Advanced Expands CDMO Services to Commercialization with China Manufacturing License - Contract PharmaContract Pharma · Wed, 05 Aug 2026 19:47:20 GMTPorton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTCell and Gene Therapy CDMO Market Share, Outlook 2026-2035 - Global Market Insights Inc.Global Market Insights Inc. · Fri, 31 Jul 2026 12:42:06 GMT